Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AURORA LABS LIMITED Director's Dealing 2019

Feb 14, 2019

64269_rns_2019-02-14_1594a608-5261-4511-930b-15ea5e6f503e.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: AURORA LABS LIMITED

ABN 44 601 164 505

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Mel Ashton
Date of last notice 30 November 2018

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevant interest.
Registered Holder: Kingsford Investments Pty Ltd

Relevant Interest: Mr Ashton is a Director and
Shareholder of Kingsford Investments Pty Ltd and a
beneficiary of the Ashton Trust.
Date of change 15 February 2019
No. of securities held prior to change 1. 50,000 Ordinary Shares
2. 100,000 Unquoted Options (Ex $1.08/ Expiry
31/01/2021)
3. 50,000 Performance Rights (Exp 31/01/2013)
Class 1. Ordinary Shares
2. Unquoted Options (Ex $1.08/Expiry 31/1/2021)
3. Performance Rights (Expiry 31 January 2023)
Number acquired 3. 70,000 Ordinary Shares
Number disposed N/A
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
$0.4841 per Share
No. of securities held after change 1. 120,000 Ordinary Shares
2. 100,000 Unquoted Options (Ex $1.08/ Expiry
31/01/2021)
3. 50,000 Performance Rights (Exp 31/01/2013)
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation
in buy-back
On-market purchase

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 337] intentionally omitted <==

----- Start of picture text -----

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and
an estimated valuation
Interest after change
----- End of picture text -----

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written clearance was required?

Yes. Please refer to the explanatory notes at the end of this Appendix 3Y.

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

If so, was prior written clearance provided to allow the
trade to proceed during this period?
No.
Please refer to the explanatory
notes at the end of this Appendix
3Y.
If prior written clearance was provided, on what date was
this provided?
Not applicable.

Additional explanatory notes regarding trade:

The Company’s Securities Trading Policy defines “Closed Period” to include 2 hours after an announcement is actually released by ASX.

The ordinary shares the subject of this Appendix 3Y were inadvertently purchased by Mr Ashton within 2 hours of the Company’s announcements of 15 February entitled ‘Aurora Labs RMT Proves Scalability at 55 Times Market Speed’ and ‘Issue of Shares under Placement’ being released on the ASX announcements platform.

Accordingly, the purchase was made within a “Closed Period” under the Securities Trading Policy and therefore did not comply with the policy.

Mr Ashton had provided prior notification to the Company Secretary of his proposed purchase of shares following the release to ASX of the above announcement. He has advised that the purchase was inadvertent due to a misunderstanding of the Closed Period.

The Company notes that the purchase was conducted after the Company had released a cleansing notice under sections 708A(5) and (6) of the Corporations Act 2001 (Cth). Further, Mr Ashton has confirmed to the Company that, at the time of purchasing the shares, he was not in possession of any price sensitive information that had not previously been released to ASX by the Company.

In addition, the Company notes that the price at which Mr Ashton purchased shares ($0.47 per share) was the same as the trading price at the time that the 2 hour Closed Period expired. Notwithstanding that the monetary benefit is not relevant for compliance purposes, it is noted that Mr Ashton did not receive any additional benefit to other investors from the purchase.

The Board (other than Mr Ashton) has considered the matter and determined not to take any disciplinary action in this instance. Whilst the share purchase did not comply with the Securities Trading Policy, the Board considers such action was genuinely inadvertent.

The Company has re-issued copies of the Securities Trading Policy to all directors and reminded them of their obligations in respect of trading in the Company’s securities, including the scope of the Closed Period.

  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3